Perceptive Advisors (NASDAQ: SLDB) details 11.2% beneficial stake and warrant limits
Rhea-AI Filing Summary
Perceptive Advisors LLC, together with related entities and Joseph Edelman, reports beneficial ownership of 12,046,579 shares of Solid Biosciences Inc. common stock, representing 11.2% of the class. This percentage is based on 107,365,171 shares of common stock, including 139,933 shares issuable upon vested options held by Adam Stone.
The holding is primarily through Perceptive Life Sciences Master Fund, Ltd., which directly holds 11,833,539 common shares and 8,912,655 pre-funded warrants exercisable at $0.001 per share, subject to a 9.99% Beneficial Ownership Limitation that currently prevents any warrant exercise. Perceptive Xontogeny Venture Fund, LP directly holds 73,107 shares. Adam Stone holds options for 217,433 shares, of which 139,933 are exercisable within 60 days; the Master Fund is entitled to receive director compensation from his board service via a management fee offset.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
pre-funded warrants financial
Beneficial Ownership Limitation financial
beneficially own financial
management fee offset financial
Schedule 13D regulatory
FAQ
How much of Solid Biosciences Inc. (SLDB) does Perceptive Advisors report owning?
What securities does Perceptive Life Sciences Master Fund hold in Solid Biosciences (SLDB)?
What is the Beneficial Ownership Limitation disclosed for SLDB pre-funded warrants?
AI-generated analysis. How Rhea-AI works. Not financial advice.